Synopsis
Synopsis
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. 14919-77-8
2. Benserazide Hcl
3. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide Hydrochloride
4. Benzerazide Hydrochloride
5. Benserazide (hydrochloride)
6. 2'-(2,3,4-trihydroxybenzyl)-dl-serinohydrazide Monohydrochloride
7. Ro 4-4602/001
8. Benserazide Hydrochloride [jan]
9. 14046-64-1
10. Dl-serine 2-(2,3,4-trihydroxybenzyl)hydrazine Hydrochloride
11. 2-amino-3-hydroxy-n'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide Hydrochloride
12. Mls000028424
13. B66e5rk36q
14. Dl-serine 2-(2,3,4-trihydroxybenzyl)hydrazide Hydrochloride
15. Chebi:31262
16. (s)-2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide Hydrochloride
17. 2-amino-3-hydroxy-n'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide;hydrochloride
18. Nsc-755907
19. Smr000058421
20. Ro-4-4602
21. Dsstox_cid_25412
22. Dsstox_rid_80862
23. Dsstox_gsid_45412
24. Benserazide (as Hydrochloride)
25. 3-hydroxy-1-oxo-1-[2-(2,3,4-trihydroxybenzyl)hydrazinyl]propan-2-aminium Chloride
26. Ccris 5092
27. Sr-01000003044
28. Einecs 238-991-9
29. Unii-b66e5rk36q
30. Mfcd00078571
31. Opera_id_1594
32. Ncgc00016709-01
33. Madopa (hoffmann-laroche)
34. Cas-14919-77-8
35. Mls001148252
36. Mls002222160
37. Schembl364720
38. Spectrum1500137
39. Chembl1255778
40. Dtxsid0045412
41. Hy-b0404a
42. Benserazide Hydrochloride (jp17)
43. Benserazide Hydrochloride - Bio-x
44. Hms1570l18
45. Hms1920g05
46. Pharmakon1600-01500137
47. Bcp14068
48. Cba17287
49. Tox21_110573
50. Tox21_500233
51. Ccg-38998
52. Nsc755907
53. S2453
54. Serine, 2-(2,3,4-trihydroxybenzyl)hydrazide, Monohydrochloride, Dl-
55. Benserazide Hydrochloride [mi]
56. Akos007930267
57. Dl-serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide, Monohydrochloride
58. Tox21_110573_1
59. Ac-6825
60. H22b350
61. Lp00233
62. Nsc 755907
63. Sb44383
64. Benserazide Middot Hcl (ro 4-4602)
65. Benserazide Hydrochloride [mart.]
66. Ncgc00015163-09
67. Ncgc00093698-01
68. Ncgc00093698-02
69. Ncgc00093698-03
70. Ncgc00093698-04
71. Ncgc00093698-05
72. Ncgc00260918-01
73. As-13683
74. Bb166155
75. Benserazide Hydrochloride [who-dd]
76. B4108
77. Eu-0100233
78. Ft-0659734
79. Ft-0760799
80. Sw196391-3
81. B 7283
82. Benserazide Hydrochloride [ep Monograph]
83. D01653
84. D70746
85. Benserazide Hydrochloride, >=98% (tlc), Solid
86. A808862
87. Sr-01000003044-2
88. Sr-01000003044-8
89. W-108090
90. Q27114249
91. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazidehydrochloride
92. Benserazide Hydrochloride, European Pharmacopoeia (ep) Reference Standard
93. Dl-serine, 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide Hydrochloride
94. Serine, 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide, Hydrochloride (1:1)
95. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)-propanehydrazide Hydrochloride
96. Benserazide For Peak Identification, European Pharmacopoeia (ep) Reference Standard
97. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)-propanehydrazide Hydrochloride;benserazide Hcl
Molecular Weight | 293.70 g/mol |
---|---|
Molecular Formula | C10H16ClN3O5 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 293.0778483 g/mol |
Monoisotopic Mass | 293.0778483 g/mol |
Topological Polar Surface Area | 148 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 278 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Benserazide Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benserazide Hydrochloride, including repackagers and relabelers. The FDA regulates Benserazide Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benserazide Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benserazide Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benserazide Hydrochloride supplier is an individual or a company that provides Benserazide Hydrochloride active pharmaceutical ingredient (API) or Benserazide Hydrochloride finished formulations upon request. The Benserazide Hydrochloride suppliers may include Benserazide Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Benserazide Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benserazide Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Benserazide Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Benserazide Hydrochloride DMFs exist exist since differing nations have different regulations, such as Benserazide Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benserazide Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Benserazide Hydrochloride USDMF includes data on Benserazide Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benserazide Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benserazide Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Benserazide Hydrochloride Drug Master File in Korea (Benserazide Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Benserazide Hydrochloride. The MFDS reviews the Benserazide Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Benserazide Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Benserazide Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Benserazide Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Benserazide Hydrochloride suppliers with KDMF on PharmaCompass.
A Benserazide Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Benserazide Hydrochloride Certificate of Suitability (COS). The purpose of a Benserazide Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Benserazide Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Benserazide Hydrochloride to their clients by showing that a Benserazide Hydrochloride CEP has been issued for it. The manufacturer submits a Benserazide Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Benserazide Hydrochloride CEP holder for the record. Additionally, the data presented in the Benserazide Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Benserazide Hydrochloride DMF.
A Benserazide Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Benserazide Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Benserazide Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Benserazide Hydrochloride written confirmation (Benserazide Hydrochloride WC) is an official document issued by a regulatory agency to a Benserazide Hydrochloride manufacturer, verifying that the manufacturing facility of a Benserazide Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Benserazide Hydrochloride APIs or Benserazide Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Benserazide Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Benserazide Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Benserazide Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benserazide Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benserazide Hydrochloride GMP manufacturer or Benserazide Hydrochloride GMP API supplier for your needs.
A Benserazide Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Benserazide Hydrochloride's compliance with Benserazide Hydrochloride specifications and serves as a tool for batch-level quality control.
Benserazide Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Benserazide Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benserazide Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Benserazide Hydrochloride EP), Benserazide Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benserazide Hydrochloride USP).
LOOKING FOR A SUPPLIER?